Diagnosis and Management of Pollen-Food Allergy Syndrome to Nuts

Mattia Giovannini,Isabel J. Skypala,Jean Christoph Caubet,George Du Toit,Anna Nowak-Wegrzyn
DOI: https://doi.org/10.1016/j.jaip.2024.01.025
IF: 11.022
2024-01-27
The Journal of Allergy and Clinical Immunology In Practice
Abstract:Unstructured abstract Oral Allergy Syndrome (OAS), or Pollen Food Allergy Syndrome (PFAS) represents a common clinical conundrum when the reported trigger food is a tree nut (usually almond or hazelnut) or peanut. The PFAS may give rise to uncertainty about the potential severity of the future reactions, indications for prescribing epinephrine, and the extent of the necessary dietary avoidance. As a food allergy, secondary to cross-reactivity with airborne pollen, PFAS usually manifests towards the end of the first decade of life as contact urticaria of the oropharyngeal mucous membranes. Molecular allergology facilitates diagnosis and risk stratification by establishing the profile of sensitization. Exclusive sensitization to PR10 and profilins indicates signs and symptoms are due to PFAS, whereas sensitization to seed storage proteins with or without sensitization to PR10 and profilins may indicate a more severe primary nut allergy phenotype. Management relies on avoidance of the specific nut trigger, advice on the likelihood of more severe local or systemic symptoms, and treatment of reactions according to the severity. Future studies are needed to better delineate the risk of systemic reactions in individuals with nut PFAS, and to establish the role of food or pollen allergen immunotherapy for the prevention or moderation of this condition.
immunology,allergy
What problem does this paper attempt to address?